However, its role in liver fibrosis progression is not yet understood.25 SRC along with PRKACA, PRKCA and PRKCD must be further explored to establish their role in target therapy of hepatic fibrosis in chronic hepatitis. This evidence concerns the gene PRKACA and chronic hepatitis.